Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex
Open accessThe DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Abstract
Genetic studies have shown that the tuberous sclerosis complex (TSC) 1–TSC2–mammalian target of Rapamycin (mTOR) and the Hippo–Yes-associated protein 1 (YAP) pathways are master regulators of organ size, which are often involved in tumorigenesis. The crosstalk between these signal transduction pathways in coordinating environmental cues, such as nutritional status and mechanical constraints, is crucial for tissue growth. Whether and how mTOR regulates YAP remains elusive. Here we describe a novel mouse model of TSC which develops renal mesenchymal lesions recapitulating human perivascular epithelioid cell tumors (PEComas) from patients with TSC. We identify that YAP is up-regulated by mTOR in mouse and human PEComas. YAP inhibition blunts abnormal proliferation and induces apoptosis of TSC1–TSC2-deficient cells, both in culture and in mosaic Tsc1 mutant mice. We further delineate that YAP accumulation in TSC1/TSC2-deficient cells is due to impaired degradation of the protein by the autophagosome/lysosome system. Thus, the regulation of YAP by mTOR and autophagy is a novel mechanism of growth control, matching YAP activity with nutrient availability under growth-permissive conditions. YAP may serve as a potential therapeutic target for TSC and other diseases with dysregulated mTOR activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cross-talk also exists between Tsc1 and Tsc2 and the Hippo effector Yap as Tsc1/2-deficient cells have higher Yap levels due to less Yap degradation via the autophagosome system (83).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Regulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609 · cited 1×
“…mTORC1 inhibits the initiation of autophagy, which is a eukaryotic catabolic pathway that sequesters cellular organelles and proteins in double-membrane autophagosomes, and delivers and degrades the cargos in lysosomes (He and Klionsky, 2009; Mizushima and Komatsu, 2011; Choi et al., 2013).”
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773 · cited 1×
“It is mainly through heterodimeric GTPases RagA/B and RagC/D, which were anchored to lysosomes through Ragulator protein complex (Lamtor1-5) and v-ATPase (Sancak et al., 2010; Sancak et al., 2008; Zoncu et al., 2011).”
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653 · cited 1×
“differentiate into adipocytes and smooth muscle cells in vitro, which are two major components commonly observed in angiomyolipomas (Armulik et al., 2011).”
Autophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.024 · Cited by 2,464
Propranolol for Severe Hemangiomas of Infancy
Léauté-Labrèze, C., de la Roque, E. D., Hubiche, T., Boralevi, F., Thambo, J.-B., & Taïeb, A. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0708819 · Cited by 2,374
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331 · cited 1×
“Atg7 +/+ and Atg7 / MEFs were provided by M. Komatsu (Tokyo Metro-politan Institute of Medical Science, Tokyo, Japan; Komatsu et al., 2005) and cultured in DMEM with 10% FBS, 1% nonessential amino acid (Invit-rogen), 1% penicillin/streptomycin.”
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
A lysosome‐to‐nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
Settembre, C., Zoncu, R., Medina, D. L., Vetrini, F., Erdin, S., Erdin, S., Huynh, T., Ferron, M., Karsenty, G., Vellard, M. C., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.32 · Cited by 1,920
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., & Gray, N. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900301200 · Cited by 1,803
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Self-citationZoncu, R., Bar-Peled, L., Efeyan, A., Wang, S., Sancak, Y., & Sabatini, D. M. (2011) · Science · doi:10.1126/science.1207056 · Cited by 1,673
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648
Self-citationRegulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
Calvo, F., Ege, N., Grande-Garcia, A., Hooper, S., Jenkins, R. P., Chaudhry, S. I., Harrington, K., Williamson, P., Moeendarbary, E., Charras, G., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2756 · Cited by 1,478
Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418 · cited 7×
“…known 2254 YAP is required for tumorigenesis of TSC | Liang et al. JEM Vol. 211, No. 11 Article 2255 of YAP in Tsc2-null cells, because the amount of Ser112phosphorylated YAP, a site of the Lats1/2 kinases (Zhao et al., 2010), paralleled the increase in total YAP protein in the mutant cells (Fig.”
InfluentialBrugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384
The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells
Cordenonsi, M., Zanconato, F., Azzolin, L., Forcato, M., Rosato, A., Frasson, C., Inui, M., Montagner, M., Parenti, A. R., Poletti, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.048 · Cited by 1,381
Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.055 · Cited by 1,377
Hayashi, S., & McMahon, A. P. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0597 · Cited by 1,342
YAP1 increases organ size and expands undifferentiated progenitor cells
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252 · cited 1×
“…to mesenchymal transition and multipo-tency, which may have oncogenic properties when their activity is not kept in balance (Huang et al., 2005; Camargo et al., 2007; Dong et al., 2007; Zhao et al., 2007, 2008; Brittle et al., 2010; Cordenonsi et al., 2011; Halder et al., 2012; Tumaneng et…”
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237
The Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Peterson, T. R., Sengupta, S. S., Harris, T. E., Carmack, A. E., Kang, S. A., Balderas, E., Guertin, D. A., Madden, K. L., Carpenter, A. E., Finck, B. N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.034 · Cited by 1,229
Cargo recognition and trafficking in selective autophagy
Stolz, A., Ernst, A., & Dikic, I. (2014) · Nature Cell Biology · doi:10.1038/ncb2979 · Cited by 1,207
Efficacy and safety of sirolimus in lymphangioleiomyomatosis
McCormack, F. X., Inoue, Y., Moss, J., Singer, L. G., Strange, C., Nakata, K., Barker, A. F., Chapman, J. T., Brantly, M. L., Stocks, J. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100391 · Cited by 1,099
Bar-Peled, L., Chantranupong, L., Cherniack, A. D., Chen, W. W., Ottina, K. A., Grabiner, B. C., Spear, E. D., Carter, S. L., Meyerson, M., & Sabatini, D. M. (2013) · Science · doi:10.1126/science.1232044 · Cited by 1,080 · cited 1×
“Several protein complex, such as GATOR1 (DEPC5, Nprl2, Nprl3), GATOR2 (Mios, Seh1l, WDR24, WDR59, Sec13) and Folliculin complex (Folliculin and FNIP1) which have GAP or GEF activities toward Rag GTPase, are identified to be involved in the activation of mTORC1 by amino acids (Bar-Peled et al., 2013; Bar-Peled et al.,…”
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N., Manning, B. D., Lopez, L., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,077
Hippo signaling: growth control and beyond
Halder, G., & Johnson, R. L. (2011) · Development · doi:10.1242/dev.045500 · Cited by 1,060
Self-citationYap1 acts downstream of α-catenin to control epidermal proliferation
Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.031 · Cited by 1,036
Rheb Binds and Regulates the mTOR Kinase
Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K., & Avruch, J. (2005) · Current Biology · doi:10.1016/j.cub.2005.02.053 · Cited by 1,005
Transduction of mechanical and cytoskeletal cues by YAP and TAZ
Halder, G., Dupont, S., & Piccolo, S. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3416 · Cited by 985 · cited 1×
“…and multipo-tency, which may have oncogenic properties when their activity is not kept in balance (Huang et al., 2005; Camargo et al., 2007; Dong et al., 2007; Zhao et al., 2007, 2008; Brittle et al., 2010; Cordenonsi et al., 2011; Halder et al., 2012; Tumaneng et al., 2012; Calvo et al., 2013).”
Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels to mTORC1
Bar-Peled, L., Schweitzer, L. D., Zoncu, R., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.07.032 · Cited by 918 · cited 1×
“Several protein complex, such as GATOR1 (DEPC5, Nprl2, Nprl3), GATOR2 (Mios, Seh1l, WDR24, WDR59, Sec13) and Folliculin complex (Folliculin and FNIP1) which have GAP or GEF activities toward Rag GTPase, are identified to be involved in the activation of mTORC1 by amino acids (Bar-Peled et al., 2013; Bar-Peled et al.,…”
Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice
Tsai, P. T., Hull, C., Chu, Y., Greene-Colozzi, E., Sadowski, A. R., Leech, J. M., Steinberg, J., Crawley, J. N., Regehr, W. G., & Sahin, M. (2012) · Nature · doi:10.1038/nature11310 · Cited by 888 · cited 1×
“Deletion of Tsc1 in Purkinje cells of mouse cerebellum using L7-cre leaded to autismlike behavior of the mutant mice (Tsai et al., 2012).”
Bissler, J. J., Kingswood, J. C., Radzikowska, E., Zonnenberg, B. A., Frost, M., Belousova, E., Sauter, M., Nonomura, N., Brakemeier, S., de Vries, P. J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61767-x · Cited by 880
Hippo pathway regulation by cell morphology and stress fibers
Wada, K.-I., Itoga, K., Okano, T., Yonemura, S., & Sasaki, H. (2011) · Development · doi:10.1242/dev.070987 · Cited by 849
Franz, D. N., Belousova, E., Sparagana, S., Bebin, E. M., Frost, M., Kuperman, R., Witt, O., Kohrman, M. H., Flamini, J. R., Wu, J. Y., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61134-9 · Cited by 794
Menon, S., Dibble, C. C., Talbott, G., Hoxhaj, G., Valvezan, A. J., Takahashi, H., Cantley, L. C., & Manning, B. D. (2014) · Cell · doi:10.1016/j.cell.2013.11.049 · Cited by 766
Roux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P., & Blenis, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405659101 · Cited by 750
Carsillo, T., Astrinidis, A., & Henske, E. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.6085 · Cited by 646
Self-citationIKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway
Lee, D.-F., Kuo, H.-P., Chen, C.-T., Hsu, J.-M., Chou, C.-K., Wei, Y., Sun, H.-L., Li, L.-Y., Ping, B., Huang, W.-C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.058 · Cited by 637
TBC1D7 Is a Third Subunit of the TSC1-TSC2 Complex Upstream of mTORC1
Dibble, C. C., Elis, W., Menon, S., Qin, W., Klekota, J., Asara, J. M., Finan, P. M., Kwiatkowski, D. J., Murphy, L. O., & Manning, B. D. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.06.009 · Cited by 612 · cited 2×
“Furthermore, the dermal layer of the skin was thickened whereas the hypodermal fat form a ternary complex having GTPase activating protein (GAP) activity for the GTPase Rheb and therefore inhibiting mTOR complex 1 (mTORC1) kinase activity (Manning and Cantley, 2003; Dibble et al., 2012).”
Self-citationA Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Jiao, S., Wang, H., Shi, Z., Dong, A., Zhang, W., Song, X., He, F., Wang, Y., Zhang, Z., Wang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.010 · Cited by 602
Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products
van Slegtenhorst, M. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.6.1053 · Cited by 565
A WW domain-containing Yes-associated protein (YAP) is a novel transcriptional co-activator
Yagi, R., Chen, L.-F., Shigesada, K., Murakami, Y., & Ito, Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2551 · Cited by 558
PEComas: the past, the present and the future
Martignoni, G., Pea, M., Reghellin, D., Zamboni, G., & Bonetti, F. (2008) · Virchows Archiv · doi:10.1007/s00428-007-0509-1 · Cited by 551
Self-citationXin, M., Kim, Y., Sutherland, L. B., Qi, X., McAnally, J., Schwartz, R. J., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2011) · Science Signaling · doi:10.1126/scisignal.2002278 · Cited by 548
Self-citationThe Drosophila Tuberous Sclerosis Complex Gene Homologs Restrict Cell Growth and Cell Proliferation
Tapon, N., Ito, N., Dickson, B. J., Treisman, J. E., & Hariharan, I. K. (2001) · Cell · doi:10.1016/s0092-8674(01)00332-4 · Cited by 542
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
Zhang, H., Cicchetti, G., Onda, H., Koon, H. B., Asrican, K., Bajraszewski, N., Vazquez, F., Carpenter, C. L., & Kwiatkowski, D. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17222 · Cited by 538
Self-citationYes‐associated protein is an independent prognostic marker in hepatocellular carcinoma
Xu, M. Z., Yao, T., Lee, N. P. Y., Ng, I. O. L., Chan, Y., Zender, L., Lowe, S. W., Poon, R. T. P., & Luk, J. M. (2009) · Cancer · doi:10.1002/cncr.24495 · Cited by 528
hVps34 Is a Nutrient-regulated Lipid Kinase Required for Activation of p70 S6 Kinase
Byfield, M. P., Murray, J. T., & Backer, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507201200 · Cited by 527
Potter, C. J., Huang, H., & Xu, T. (2001) · Cell · doi:10.1016/s0092-8674(01)00333-6 · Cited by 521
Rheb fills a GAP between TSC and TOR
Manning, B. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.09.003 · Cited by 483
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
Zhang, H., Cicchetti, G., Onda, H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317222 · Cited by 482
Meikle, L., Talos, D. M., Onda, H., Pollizzi, K., Rotenberg, A., Sahin, M., Jensen, F. E., & Kwiatkowski, D. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5540-06.2007 · Cited by 462
Self-citationYAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29
Tumaneng, K., Schlegelmilch, K., Russell, R. C., Yimlamai, D., Basnet, H., Mahadevan, N., Fitamant, J., Bardeesy, N., Camargo, F. D., & Guan, K.-L. (2012) · Nature Cell Biology · doi:10.1038/ncb2615 · Cited by 453
Modulating F‐actin organization induces organ growth by affecting the Hippo pathway
Sansores‐Garcia, L., Bossuyt, W., Wada, K., Yonemura, S., Tao, C., Sasaki, H., & Halder, G. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.157 · Cited by 430
Morin-Kensicki, E. M., Boone, B. N., Howell, M., Stonebraker, J. R., Teed, J., Alb, J. G., Magnuson, T. R., O'Neal, W., & Milgram, S. L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.77-87.2006 · Cited by 429
Regulation of TORC1 in Response to Amino Acid Starvation via Lysosomal Recruitment of TSC2
Demetriades, C., Doumpas, N., & Teleman, A. A. (2014) · Cell · doi:10.1016/j.cell.2014.01.024 · Cited by 420
Ota, M., & Sasaki, H. (2008) · Development · doi:10.1242/dev.027151 · Cited by 391
Cytokinesis Failure Triggers Hippo Tumor Suppressor Pathway Activation
Ganem, N. J., Cornils, H., Chiu, S.-Y., O’Rourke, K. P., Arnaud, J., Yimlamai, D., Théry, M., Camargo, F. D., & Pellman, D. (2014) · Cell · doi:10.1016/j.cell.2014.06.029 · Cited by 373
Uhlmann, E. J., Wong, M., Baldwin, R. L., Bajenaru, M. L., Onda, H., Kwiatkowski, D. J., Yamada, K., & Gutmann, D. H. (2002) · Annals of Neurology · doi:10.1002/ana.10283 · Cited by 372 · cited 1×
“An astrocyte specific Tsc1 knockout was generated by crossing a floxed allele of Tsc1 (Tsc1fl/fl) and GFAP-Cre allele (Uhlmann et al., 2002).”
Self-citationActivity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning
Cai, S.-L., Tee, A. R., Short, J. D., Bergeron, J. M., Kim, J., Shen, J., Guo, R., Johnson, C. L., Kiguchi, K., & Walker, C. L. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200507119 · Cited by 359
Wienecke, R., König, A., & DeClue, J. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16409 · Cited by 356
Smith, E. M., Finn, S. G., Tee, A. R., Browne, G. J., & Proud, C. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414499200 · Cited by 355
Goberdhan, D. C. I., Paricio, N., Goodman, E. C., Mlodzik, M., & Wilson, C. (1999) · Genes & Development · doi:10.1101/gad.13.24.3244 · Cited by 354
Coordinated regulation of protein synthesis and degradation by mTORC1
Zhang, Y., Nicholatos, J., Dreier, J. R., Ricoult, S. J. H., Widenmaier, S. B., Hotamisligil, G. S., Kwiatkowski, D. J., & Manning, B. D. (2014) · Nature · doi:10.1038/nature13492 · Cited by 350
Self-citationOnda, H., Lueck, A., Marks, P. W., Warren, H. B., & Kwiatkowski, D. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7319 · Cited by 349
Self-citationXiao, G.-H., Shoarinejad, F., Jin, F., Golemis, E. A., & Yeung, R. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6097 · Cited by 349
Kandt, R. S., Haines, J. L., Smith, M., Northrup, H., Gardner, R. J. M., Short, M. P., Dumars, K., Roach, E. S., Steingold, S., Wall, S., et al. (1992) · Nature Genetics · doi:10.1038/ng0992-37 · Cited by 337
Self-citationFan, R., Kim, N.-G., & Gumbiner, B. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216462110 · Cited by 336
The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho
Lamb, R. F., Roy, C., Diefenbach, T. J., Vinters, H. V., Johnson, M. W., Jay, D. G., & Hall, A. (2000) · Nature Cell Biology · doi:10.1038/35010550 · Cited by 326
PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development
Huang, H., Potter, C. J., Tao, W., Li, D.-M., Brogiolo, W., Hafen, E., Sun, H., & Xu, T. (1999) · Development · doi:10.1242/dev.126.23.5365 · Cited by 321
Kenerson, H. L., Aicher, L. D., True, L. D., & Yeung, R. S. W. (2002) · PubMed · Cited by 315
Kobayashi, T., Minowa, O., Kuno, J., Mitani, H., Hino, O., & Noda, T. (1999) · PubMed · Cited by 304
Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1
Hossain, Z., Ali, S. M., Ko, H. L., Xu, J., Ng, C. P., Guo, K., Qi, Z., Ponniah, S., Hong, W., & Hunziker, W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605266104 · Cited by 297
Zhang, W., Gao, Y., Li, P., Shi, Z., Guo, T., Li, F., Han, X., Feng, Y., Zheng, C., Wang, Z., et al. (2014) · Cell Research · doi:10.1038/cr.2014.10 · Cited by 296
Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila
Fernández, B. G., Gaspar, P., Brás-Pereira, C., Jezowska, B., Rebelo, S. R., & Janody, F. (2011) · Development · doi:10.1242/dev.063545 · Cited by 293
Chronic Renal Diseases: Renoprotective Benefits of Renin–Angiotensin System Inhibition
Remuzzi, G., Ruggenenti, P., & Perico, N. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-8-200204160-00010 · Cited by 272
Induction of the neural crest and the opportunities of life on the edge
Huang, X., & Saint-Jeannet, J.-P. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.07.033 · Cited by 262
Gao, X., Neufeld, T. P., & Pan, D. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9680 · Cited by 260
A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling
Findlay, G. M., Yan, L., Procter, J., Mieulet, V., & Lamb, R. F. (2007) · Biochemical Journal · doi:10.1042/bj20061881 · Cited by 257
Magri, L., Cambiaghi, M., Cominelli, M., Alfaro-Cervello, C., Cursi, M., Pala, M., Bulfone, A., Garcìa-Verdugo, J. M., Leocani, L., Minicucci, F., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.09.008 · Cited by 256
Benvenuto, G., Li, S., Brown, S. J., Braverman, R., Vass, W. C., Cheadle, J. P., Halley, D. J., Sampson, J. R., Wienecke, R., & DeClue, J. E. (2000) · Oncogene · doi:10.1038/sj.onc.1204009 · Cited by 252
Kobayashi, T., Minowa, O., Sugitani, Y., Takai, S., Mitani, H., Kobayashi, E., Noda, T., & Hino, O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151033798 · Cited by 251
Plank, T. L., Yeung, R. S. W., & Henske, E. P. (1998) · PubMed · Cited by 248
Self-citationTEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation
Chan, S. W., Lim, C. J., Loo, L. S., Chong, Y. F., Huang, C., & Hong, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901568200 · Cited by 239
Oka, T., Remue, E., Meerschaert, K., Vanloo, B., Boucherie, C., Gfeller, D., Bader, G. D., Sidhu, S. S., Vandekerckhove, J., Gettemans, J., et al. (2010) · Biochemical Journal · doi:10.1042/bj20100870 · Cited by 216
El-Hashemite, N., Zhang, H., Henske, E. P., & Kwiatkowski, D. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13044-9 · Cited by 196
Self-citationTumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent
Parkhitko, A., Myachina, F., Morrison, T. A., Hindi, K. M., Auricchio, N., Karbowniczek, M., Wu, J. J., Finkel, T., Kwiatkowski, D. J., Yu, J. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104361108 · Cited by 189
Self-citationOrgan Size Control by Hippo and TOR Pathways
Tumaneng, K., Russell, R. C., & Guan, K.-L. (2012) · Current Biology · doi:10.1016/j.cub.2012.03.003 · Cited by 183
Chen, H. I., Einbond, A., Kwak, S.-J., Linn, H., Koepf, E., Peterson, S., Kelly, J. W., & Sudol, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17070 · Cited by 179
Goto, J., Talos, D. M., Klein, P., Qin, W., Chekaluk, Y. I., Anderl, S., Malinowska, I. A., Di Nardo, A., Bronson, R. T., Chan, J. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106454108 · Cited by 179
Self-citationThe Hippo Signaling Pathway Interactome
Kwon, Y., Vinayagam, A., Sun, X., Dephoure, N., Gygi, S. P., Hong, P., & Perrimon, N. (2013) · Science · doi:10.1126/science.1243971 · Cited by 176
Loss of heterozygosity in tuberous sclerosis hamartomas.
Sepp, T., Yates, J. R., & Green, A. J. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.11.962 · Cited by 166
Astrinidis, A., Cash, T. P., Hunter, D., Walker, C. L., Chernoff, J., & Henske, E. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205962 · Cited by 164
Self-citationREDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling
Dennis, M. D., Coleman, C. S., Berg, A., Jefferson, L. S., & Kimball, S. R. (2014) · Science Signaling · doi:10.1126/scisignal.2005103 · Cited by 159
Four-Jointed Modulates Growth and Planar Polarity by Reducing the Affinity of Dachsous for Fat
Brittle, A. L., Repiso, A., Casal, J., Lawrence, P. A., & Strutt, D. (2010) · Current Biology · doi:10.1016/j.cub.2010.03.056 · Cited by 152
Amino Acid Signaling to MTOR Mediated by Inositol Polyphosphate Multikinase
Kim, S., Kim, S. F., Maag, D., Maxwell, M. J., Resnick, A. C., Juluri, K. R., Chakraborty, A., Koldobskiy, M. A., Cha, S. H., Barrow, R., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.007 · Cited by 144
Pea, M., Martignoni, G., Zamboni, G., & Bonetti, F. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199609000-00012 · Cited by 137
Self-citationJin, F., Wienecke, R., Xiao, G. H., Maize, J. C., DeClue, J. E., & Yeung, R. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9154 · Cited by 127
Karbowniczek, M., Yu, J. J., & Henske, E. P. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63843-6 · Cited by 125
Self-citationAberrant β-Catenin Signaling in Tuberous Sclerosis
Mak, B. C., Kenerson, H. L., Aicher, L. D., Barnes, E. A., & Yeung, R. S. W. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62958-6 · Cited by 114
Zhou, J., Shrikhande, G., Xu, J., McKay, R. M., Burns, D. K., Johnson, J. E., & Parada, L. F. (2011) · Genes & Development · doi:10.1101/gad.16750211 · Cited by 113
Matsumoto, S., Bandyopadhyay, A., Kwiatkowski, D. J., Maitra, U., & Matsumoto, T. (2002) · Genetics · doi:10.1093/genetics/161.3.1053 · Cited by 106
Self-citationEmbryology of the Neural Crest: Its Inductive Role in the Neurocutaneous Syndromes
Sarnat, H. B., & Flores‐Sarnat, L. (2005) · Journal of Child Neurology · doi:10.1177/08830738050200080101 · Cited by 101
Zhang, X., Milton, C. C., Humbert, P. O., & Harvey, K. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4592 · Cited by 84
Mask Proteins Are Cofactors of Yorkie/YAP in the Hippo Pathway
Sidor, C., Brain, R., & Thompson, B. J. (2013) · Current Biology · doi:10.1016/j.cub.2012.11.061 · Cited by 73
Homeodomain-Interacting Protein Kinase Regulates Hippo Pathway-Dependent Tissue Growth
Poon, C. L. C., Zhang, X., Lin, J. I., Manning, S. A., & Harvey, K. F. (2012) · Current Biology · doi:10.1016/j.cub.2012.06.075 · Cited by 72
Zhou, J., Brugarolas, J., & Parada, L. F. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp398 · Cited by 64
Franz, D. N. (2013) · Biologics · doi:10.2147/btt.s25095 · Cited by 59
Zhang, L., Ye, D., Pan, H., Wei, K., Wang, L., Wang, X.-D., Shen, G.-F., & Zhang, Z. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.06.003 · Cited by 42
The Hippo pathway—From top to bottom and everything in between
Tapon, N., & Harvey, K. F. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.08.007 · Cited by 17
Cited by
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
YAP/TAZ at the Roots of Cancer
Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970
“…also suggests that, in some contexts, YAP/TAZ constantly rejuvenate cancer cells by promoting basal levels of autophagy to avoid senescence (Garcia-Prat et al., 2016; Song et al., 2015a), while still opposing cell death caused by an excess of autophagy in the tumor bulk (Liang et al., 2014).”
BackgroundMechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667
“In fact, ubiquitination of other Hippo pathway components has also been reported (Wang et al. 2012; Lignitto et al. 2013; Rodrigues-Campos andThompson 2014), indicating that ubiquitination is a common regulatory mechanism often resulting in degradation of the Hippo pathway components and…”
YAP/TAZ upstream signals and downstream responses
Totaro, A., Panciera, T., & Piccolo, S. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0142-z · Cited by 1,086
The Hippo Signaling Pathway in Development and Disease
Zheng, Y., & Pan, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.06.003 · Cited by 867
“In addition, the nutrient and energy sensor Target of Rapamycin (TOR) has been shown to promote Yki/YAP activity in Drosophila and mammalian cells (Liang et al., 2014; Parker and Struhl, 2015).”
Background
Metadata
- Authors
- Liang, N., Zhang, C., Dill, P., Panasyuk, G., Pion, D., Koka, V., Gallazzini, M., Olson, E. N., Lam, H., Henske, E. P., Dong, Z., Apte, U., Pallet, N., Johnson, R. L., Terzi, F., Kwiatkowski, D. J., Scoazec, J.-Y., Martignoni, G., & Pende, M.
- Affiliations
- Inserm (FR)
- The University of Texas Southwestern Medical Center (US)
- Brigham and Women's Hospital (US)
- Charlie Norwood VA Medical Center (US)
- University of Kansas Medical Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Hospices Civils de Lyon (FR)
- University of Verona (IT)
- Corresponding author
- Pende, Mario
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2014-10-06
- Volume
- 211
- Issue
- 11
- Pages
- 2249-2263
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4203941
- OpenAlex
- W2111900780
- Cited by
- 205
- References
- 122
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 13 · 2023: 14 · 2022: 23 · 2021: 24 · 2020: 23 · 2019: 24 · 2018: 19 · 2017: 17 · 2016: 13 · 2015: 15 · 2014: 1
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- Association pour la Recherche sur le Cancer
- Institut National de la Santé et de la Recherche Médicale
- China Scholarship Council
- Institut National Du Cancer
- National Cancer Institute (P01CA120964)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK096556)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- tuberous sclerosis complex, YAP, mTOR, autophagy, Hippo signaling pathway, PEComa, TSC1, TSC2, protein degradation, lysosomes, organ size control, therapeutic target, tumor growth control
- MeSH terms
- Tuberous Sclerosis Complex 1 Protein, Verteporfin, YAP-Signaling Proteins, Animals, Autophagy, Cell Survival, Disease Models, Animal, Gene Expression Regulation, Humans, Immunohistochemistry, Kidney, Phosphoproteins, Porphyrins, Tuberous Sclerosis, Signal Transduction, Up-Regulation, Apoptosis, Angiomyolipoma, Mice, Knockout, Cell Cycle Proteins, Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing, Cell Proliferation, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.